The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 09, 2024
Filed:
Dec. 27, 2019
Immunolight, Llc., Detroit, MI (US);
Duke University, Durham, NC (US);
Harold Walder, Oak Island, NC (US);
Frederic A. Bourke, Jr., Aspen, CO (US);
Zakaryae Fathi, Raleigh, NC (US);
Wayne F. Beyer, Jr., Ivanhoe, VA (US);
Mark Dewhirst, Durham, NC (US);
Mark Oldham, Durham, NC (US);
Justus Adamson, Durham, NC (US);
Michael Nolan, Raleigh, NC (US);
IMMUNOLIGHT, LLC., Detroit, MI (US);
DUKE UNIVERSITY, Durham, NC (US);
Abstract
A system and method for imaging or treating a disease in a human or animal body. The system provides to the human or animal body a pharmaceutical carrier including one or more phosphors which are capable of emitting ultraviolet or visible light into the body and which provide x-ray contrast. The system includes one or more devices which infuse a diseased site with a photoactivatable drug and the pharmaceutical carrier, an initiation energy source comprising an x-ray or high energy source which irradiates the diseased site with at least one of x-rays, gamma rays, or electrons to thereby initiate emission of said ultraviolet or visible light into the body, and a processor programmed to at least one of 1) produce images of the diseased site or 2) control a dose of said x-rays, gamma rays, or electrons to the diseased site for production of said ultraviolet or visible light at the diseased site to activate the photoactivatable drug.